A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
NCT04504253
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DIETARY_SUPPLEMENT:
Creatine monohydrate
DRUG:
Placebo
Sponsor
University of Utah